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Background: Learning processes or language development are only some of the
cognitive functions that differ qualitatively between men and women. Gender differences
in the brain structure seem to be behind these variations. Indeed, this sexual dimorphism
at neuroanatomical level is accompanied unequivocally by differences in the way that
aging and neurodegenerative diseases affect men and women brains.
Objective: The aim of this study is the analysis of neuronal density in four areas of
the hippocampus, and entorhinal and frontal cortices to analyze the possible gender
influence during normal aging and in Alzheimer’s disease (AD).
Methods: Human brain tissues of different age and from both sexes, without
neurological pathology and with different Braak’s stages of AD, were studied. Neuronal
density was quantified using the optical dissector.
Results: Our results showed the absence of a significant neuronal loss during aging
in non-pathological brains in both sexes. However, we have demonstrated specific
punctual significant variations in neuronal density related with the age and gender in
some regions of these brains. In fact, we observed a higher neuronal density in CA3 and
CA4 hippocampal areas of non-pathological brains of young men compared to women.
During AD, we observed a negative correlation between Braak’s stages and neuronal
density in hippocampus, specifically in CA1 for women and CA3 for men, and in frontal
cortex for both, men and women.
Conclusion: Our data demonstrated a sexual dimorphism in the neuronal vulnerability
to degeneration suggesting the need to consider the gender of the individuals in future
studies, regarding neuronal loss in aging and AD, in order to avoid problems in interpreting
data.
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INTRODUCTION
Compelling evidences of changes in the human brain, at the anatomical and molecular level,
related with aging and during Alzheimer’s disease (AD) have been described by different authors.
Anatomically, it has found a clear decrease in the volume and weight of the brain and histologically
an increase in the size of astrocytes and microglia, as well in the neuronal lipofuscin content
Abbreviations: AD, Alzheimer’s disease; CNS, central nervous system; NFT, neurofibrillary tangles; SD, standard deviation;
SP, senile plaques.
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(Mrak et al., 1997; Sheffield and Berman, 1998; Schultz et al.,
2004; Dorszewska, 2013). However, there is a great controversy
about the occurrence and extent of neuronal loss processes
in these situations. Some influential papers from as early as
the 1950s, looking for changes in neuronal density in two-
dimensional space concluded that a substantial loss of neurons
occurs with age. The percentage of this loss varies from 10
to 60% depending on the methodology employed and the
neuronal population examined. Moreover, it has been shown
that this death is cell type-dependent since some populations
do not exhibit signs of degeneration and others, as cerebral
cortex and hippocampus, are particularly affected (Brody, 1955;
Colon, 1972). In AD, neuronal loss constitutes one of the major
pathological markers that extensively affect different brain areas
as entorhinal or prefrontal cortex. This decrease in the neuronal
population that reaches 90% correlates well with the severity
of the disease (Terry, 2006; Zilkova et al., 2006; Padurariu
et al., 2012). The development of more accurate procedures for
counting neurons over the last years confirmed these previous
observations and open new avenues to better understand how
the brain changing with age and with the progression of different
neurodegenerative diseases.
The application of stereological techniques to several species,
including humans, has led to the conclusion that the decline in
neuronal number during aging is not significant in brain regions
such as neocortex or hippocampus (West and Gundersen, 1990;
Pakkenberg and Gundersen, 1997; Hof and Morrison, 2004) or
in some vestibular nuclei (Alvarez et al., 2000). However, it has
been reported a highly significant correlation between loss of
neurons and age in the entorhinal cortex (Simic et al., 2005) and
in the human medial vestibular nucleus (Alvarez et al., 1998).
In AD patients, the loss of neurons takes place primarily in the
neocortex, hippocampus and entorhinal region (Terry, 2006).
Interestingly, the characteristic degenerative processes of AD do
not affect equally all cell types. As an example, the pyramidal cells
in the entorhinal cortex and the CA1 and subiculum regions of
the hippocampus seem to be more vulnerable to neurofibrillary
tangles (NFT) formation and neurodegeneration than cells of
other hippocampal areas (Adachi et al., 2003; Kerchner et al.,
2010; Padurariu et al., 2012). The same phenomenon has
been observed in the neocortex. This specific vulnerability to
degeneration assumes particular importance in the pyramidal
cells that furnish long cortico-cortical projections, leading to a
global disruption of interconnections among association cortices
(Desikan et al., 2010). In contrast, primary sensory and motor
areas exhibit minimal loss of neurons.
Several authors have described evidences for sexual
dimorphism in the number and cell density in the central
nervous system (CNS). In fact, studies on cerebral cortex show
that men have 15% more cortical neurons and 13% greater
total neuronal density than women, without variations in
thickness (Pakkenberg and Gundersen, 1997; Rabinowicz et al.,
2002). Complementary studies achieved by magnetic resonance,
confirmed that some brain areas such as human cerebellar
cortex or gray matter of the left amygdala (Raz et al., 1997)
exhibit larger volumes in men than in women (Raz et al., 2004;
Sowell et al., 2007). On the contrary, women show larger right
striatal and bilateral hippocampal gray matter volumes than men
(Neufang et al., 2009). Another sexual dimorphic brain structure
in humans is the corpus callosum, which is higher in women
than in men (DeLisi et al., 1989). All these gender differences
may underline gender-specific abilities and susceptibilities to
disease, probably influenced by gonadal hormones i.e., estrogen,
testosterone and progesterone, in certain areas of the brain. The
sexual differentiation of a particular brain region is related to
its hormonal environment that comprises local and circulating
hormones of the CNS (Neufang et al., 2009). Thus, it seems
reasonable to expect that the loss of neuronal cells that occurs in
the aging processes as well as in several pathologies of the CNS
as AD is influenced by these sexual differences.
In recent years, some studies have been interested in the
potential impact of sex on age-related brain changes and in
the development of different neurodegenerative diseases. As a
rule, these studies concluded that men exhibited greater age-
related brain atrophy than women over the entire life expectancy
(Gur et al., 1999); this effect is enhanced in the frontal and
temporal lobes (Raz et al., 1997; Gur et al., 2002). Meanwhile,
a significant reduction of gray matter in women has been
reported in the parietal lobes and hippocampus (Raz et al., 2004;
Sowell et al., 2007). According with different authors, there is a
higher prevalence and incidence of AD in women than in men
(Breitner et al., 1988; Fratiglioni et al., 1997; Viña and Lloret,
2010; Alzheimer’s Association, 2015). It has been postulated
that estrogen deficiency, following menopause, may contribute
to the etiology of the disease. In a 12 case-control and cohort
studies conducted in the 1990s, it was suggested that estrogen
therapy could delay the onset or contribute to the prevention
and/or significantly attenuation of AD (Sundermann et al., 2006),
but this question is still under discussion (Asthana et al., 1999;
Henderson et al., 2000; Mulnard et al., 2000; Henderson, 2014).
The bulk of evidence suggests that sexual dimorphism in
the neuronal content may determine the way that aging and
neurodegenerative processes affect men and women brains. The
aim of this research work is to study the changes in neuronal
density in hippocampus and entorhinal and frontal cortices of
both, men and women, in order to analyze the possible gender
influence during normal aging and in AD.
MATERIALS AND METHODS
Human Tissues
Use of human brain tissues were approved by “Comité Ético
de Investigación Clínica Regional del Principado de Asturias”
as follows. These studies were granted waivers of consent on
the following bases: (1) samples were gathered retrospectively
from pathology archives of necropsies performed for diagnostic
purposes; (2) patient identities were anonymized and completely
delinked from unique identifiers; and (3) there was no risk to the
participants.
Human brain tissues were provided by The Pathologic
Anatomy Service of the University Central Hospital of Asturias
and the Bank of Neurologic Tissues of the Clinic Hospital
of Barcelona. This material was the same used in recent
studies of our group (Ordóñez et al., 2012; Martínez et al.,
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2013; Navarro et al., 2013). Seventy-two cases were employed.
Thirty-six individuals with not known neurological, psychiatric,
or neuropathological disorders (18men and 18women) were
divided in three groups according to their age: the first group
includes individuals in their 30’s and 40’s; the second from
those in their 50’s to the ones in their 70’s; and the last one
those older than 80. Other thirty-six cases of AD (18men and
18women) were divided in three groups based on their AD
neuropathological stage, according to Braak’s criteria (Braak
and Braak, 1991). Postmortem intervals ranged between 2 and
6 h. The pieces from human frontal cortex (Brodmann’s area
9), hippocampus and adjacent entorhinal cortex were fixed
by immersion in 10% buffered formalin. After fixation, they
were washed in distilled water, dehydrated through successive
alcohols, cleared in two baths of butyl acetate, embedded in
paraffin, and placed in a suitable mold. Transverse sections about
10µm thick were obtained and attached to gelatin-covered slides,
deparaffined in xylene, and rehydrated.
Neurons, Senile Plaques, Neurofibrillar
Tangles, and Amyloid-Beta Staining
Alternated sections were stained using a Nissl-like method
developed in our laboratory to counterstaining paraffin sections
stained with alcoholic Congo Red to show amyloid. This method
allows a clear discrimination between neurons and the rest of
nervous cells (Navarro et al., 1999). To visualize the typical
cerebral markers of the AD neuropathology, the silver technique
of Reusche (1991) and a modification of the Congo red method
developed in our laboratory (Navarro et al., 1999, 2013) were
used.
Neuronal Counting
The estimation of the total number of neurons was carried out
using the optical fractionator principle. Stereological analysis was
performed using an Olympus BX-51 microscope with Olympus
CAST system version 2.0 (Olympus, Denmark A/S, Albertslund,
Denmark). The analyzed area (field included by a 20x lens), was
delimited. From a random start position, a counting frame was
superimposed on the image and neurons were systematically
sampled using a 60x lens (Plan Apo N 60x /1.42 oil, Olympus)
and the nucleolus as the sampling unit. The sampling frequency
was chosen by adjusting the xy-axis step length so that up to 200
cells were counted in each specimen.
Neuronal counting was undertaken on five sections at
different levels (separated by 100µm). For each section, the
neuronal density was calculated by dividing the total number
of neurons by the area of the sections surveyed. The mean
value of each brain region studied was used for the statistical
analysis. Hippocampal variations in neuronal density was
assessed separately in each anatomical region (CA1, CA2, CA3,
CA4; Supplementary Figure 1).
Statistical Analysis
The data in the graphs are presented as the mean ± SD.
All statistical calculations were conducted using SPSS 15.0 for
Windows. The test of Kolmogorov–Smirnov with the correction
of Lilliefors was used to evaluate the fit of the data to a
normal distribution. One-way ANOVA followed by multiple
comparisons Tukey’s test was performed to analyze changes
in neuronal density between the different groups of age or
the Braak’s stages of AD. The Student’s t-test (two-tailed) was
used to analyze possible gender differences. Finally, a Pearson
Correlation analysis was used to evaluate the relationship
between neuronal density and age or Braak’s stage. p < 0.05 was
defined as statistically significant.
RESULTS
Changes in Neuronal Density during Aging
The quantitative study showed that there were no significant
differences regarding neuronal density in CA1, CA2, and
entorhinal cortex between women and men, and between
groups of age (Figures 1A,B,E). However, the CA3 and CA4
hippocampal areas of the youngest group showed a higher value
in men than in women (Figures 1C,D, 2A–D). These differences
disappeared with age since the men group tends to suffer a
decrease in neuronal density. A correlation between neuronal
density and the age of subjects was not found in these areas;
only a statistical significant diminution in neuronal density in
men of median age was observed respect to the youngest group.
In frontal cortex, both sexes showed a decrease in neuronal
density in the 50’s–70’s and a significant increase in elderly with
respect to median age subjects (Figures 1F, 2E–H). However, no
correlation between the number of neurons per area and age was
found in this brain area.
Morphological Changes of Hippocampus
and Entorhinal Cortex during Aging
When we analyzed the morphological brain changes during
aging in both sexes, we first observed some shrinking neurons
in the different areas of the hippocampus in aged individuals.
These cells undergo a wide range of modifications in their somas
and nuclei that made them look larger and thinner, even in
some cases, due to the intensity of the nuclear staining, it was
impossible to distinguish the nucleolus (Figure 3A). Moreover,
we often observed lipofuscin granules in non-degenerating
neurons (Figure 3B).
The number of astrocytes increased with age in the entorhinal
cortex, CA2, CA3, and CA4 while it was always scarce in the
CA1 and subiculum. These glial cells also accumulated lipofuscin
granules with age and their nuclei turned rounder and bigger
than in the youngest subjects (Figure 3C). We also observed,
mainly in the oldest individuals, corpora amylacea in contact
to the pial surface, and in the CA4 close to the dentate gyrus
(Figure 3D). The entorhinal cortex of some individuals of the
over 80 group showed diffuse senile plaques (SP) and few isolated
mature SP (Figure 3E), whereas the presence of NFT was not a
common feature. In the subpial area, we found some vessels with
a great extracellular deposit of amyloid protein (Figure 3F). It
is important to note that these changes are not related with the
gender of the subjects.
In the frontal cortex, we found the same morphological
changes described previously for the hippocampus and the
entorhinal cortex. In fact, we also found an increased neuronal
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FIGURE 1 | Quantitative changes in neuronal density in certain hippocampal fields (CA1–4) and in frontal and entorhinal cortices between men and
women during aging. (A) CA1 hippocampal area. (B) CA2 hippocampal area. (C) CA3 hippocampal area. (D) CA4 hippocampal area. (E) Entorhinal cortex. (F)
Frontal cortex. Bars represent mean density in a 20x field ± SD (n = 6). *Statistically significant differences, p ≤ 0.05. Women, white bars; Men, black bars.
content of lipofuscin and a higher number of corpora amylacea
in contact with the pial surface in aged individuals. SP (mainly
diffuse SP) were only observed in the oldest subjects who
also showed inconstant perivascular amyloid deposits (data not
shown). Once again, all these changes are related with age and
not with gender.
Neuronal Density in Alzheimer’s Disease
The analysis of cellular counting demonstrated that neuronal
density in AD is not related with the gender or the degree of
disease progression in the CA2, CA4, and entorhinal cortex,
since significant differences were not found in these areas
between sexes and Braak’s stages (Figures 4B,D,E). In the CA1
hippocampal area, women displayed a decrease in the number of
neurons per mm2 when we compared the initial with the advance
stages of AD (Figures 4A, 5A,B), with a negative correlation
between neuronal density and Braak’s stage (r=−0.662, p< 0.01;
Table 1). Meanwhile, men did not show significant differences in
this area. In contrast, in the CA3 hippocampal area men but not
women showed a statistical significant decrease in the neuronal
density in the later stages of AD (Figures 4C, 5C,D), and a
negative correlation between these two parameters (r =−0.662,
p < 0.01; Table 1).
In the frontal cortex, we found that both men and women
showed a statistical significant decrease in the neuronal density
in the later stages of AD (Figure 4F). Moreover, a clear negative
correlation between the number of neurons per area analyzed and
the progression of the pathology in both, women (r = −0.537,
p < 0.01; Table 1) and men (r = −0.514, p < 0.01; Table 1), was
detected.
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FIGURE 2 | Changes in neuronal density in hippocampus and frontal cortex between men and women during aging. Representative microphotographs of
human brain sections of non-pathological individuals contrasted with a Nissl method modification. (A) Hippocampus (CA3) of a 37 years old man. (B) Hippocampus
(CA3) of a 35 years old woman. (C) Hippocampus (CA4) of a 37 years old man. (D) Hippocampus (CA4) of a 35 years old woman. (E) Frontal cortex of a 40 years old
man. (F) Frontal cortex of a 65 years old man. (G) Frontal cortex of a 37 years old woman. (H) Frontal cortex of a 69 years old woman. Bar, 60µm.
Morphological Changes of Hippocampus
and Entorhinal Cortex in Alzheimer’s
Disease
The morphological brain changes observed in individuals with
AD were similar to those previously described for the non-
pathological cases over 80’s (i.e., changes in neuronal features).
As expected, the number of NFT and SP (as well as their level
of development) was higher in AD subjects, increasing with the
Braak’s stage. Thus, we found diffuse isolated SP and some NFT
in the entorhinal cortex of patients diagnosed with Braak’s stage I-
II. In advanced stages, the number of diffuse and mature SP with
amyloid core increased notably in this brain area (Figures 6A,C).
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FIGURE 3 | Morphological changes in hippocampus and entorhinal cortex during aging in both sexes. Representative microphotographs of human brain
sections of non-pathological individuals contrasted with a Nissl method modification (A–D), silver technique of Reusche (E) and a modification of Congo Red method
(F). (A) Shrinking neurons in the hippocampus of an 80 years old man. (B) Frontal cortex of a 75 years old woman, lipofuscin in neurons can be observed. (C)
Hippocampus (CA3) of an 80 years old man, several astrocytes with lipofuscin granules are showed (arrowhead). (D) Hippocampus (CA4) of a 75 years old woman,
several corpora amylacea can be observed (arrows). (E) Diffuse senile plaques in the entorhinal cortex of an 85 years old man. (F) Vessels with amyloid (red
fluorescence) in frontal cortex of an 80 years old woman. Bars: (A,C), 60 µm; (B,D), 10µm; (E), 40µm; (F), 50µm.
Finally, these characteristic AD hallmarks appeared in CA1 and
CA2 (Figure 6B) and in a great number in the entorhinal cortex
(Figure 6D) in the last stages of the disease.
Respect to the glia, we observed the presence of microglial
cells, close to neuronal debris, in advanced stages of AD. Likewise,
reactive astrocytes with pale big round nuclei and an important
accumulation of lipofuscin granules were detected in all areas
under analysis (except CA1 and subiculum) and in all Braak’s
stages. The number of corpora amylacea was higher in AD cases
than in non-pathological ones.
In the frontal cortex of AD brains, we observed the same
morphological changes as we did in the oldest subjects without
pathology, but once again, lipofuscin accumulation as well as the
presence of corpora amylacea and microglia seems to be higher
in the AD samples. In the same way, the amount of amyloid
protein and the number of SP and NFT are considerably higher
in AD individuals than in those older subjects without pathology
(data not shown). All the changes described here are common
and similar to both sexes.
DISCUSSION
In this work, we look for changes in neuronal density during
aging and in AD, in men and women, in some particularly
vulnerable brain areas as hippocampus and entorhinal and
frontal cortices.
Classical reports analyzing changes in neuronal density
in two-dimensional space concluded that the percentage of
substantial loss, which occurs with age, varies between 10 and
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FIGURE 4 | Quantitative changes in neuronal density in certain hippocampal fields (CA1–4) and in frontal and entorhinal cortices between men and
women during AD progression (I–VI Braak’s stages). (A) CA1 hippocampal area. (B) CA2 hippocampal area. (C) CA3 hippocampal area. (D) CA4 hippocampal
area. (E) Entorhinal cortex. (F) Frontal cortex. Bars represent mean density in a 20x field ± SD (n = 6). *Statistically significant differences, p ≤ 0.05. Women, white
bars; Men, black bars.
60 %, depending on the study and the neuronal population
examined. Some studies, employing stereological-based sampling
to derive estimates of cell number, reported that neuronal
loss during aging is either undetectable or relative mild (West
and Gundersen, 1990; Hof and Morrison, 2004). Our results
are in concordance with these studies since we did not
find a significantly neuronal loss with age. Importantly, we
demonstrated a negative correlation between Braak’s stage and
neuronal density in some areas of AD brains. In this sense, West
et al. concluded that neurodegenerative processes associated with
normal aging and with AD are qualitatively different (West
et al., 1994). A possible explanation could be that individuals
without neurodegenerative pathology are able to mitigate the
constant increased production of free radicals that naturally
occurs with age, avoiding the neuronal loss. Interestingly, in
several areas as frontal cortex middle-aged individuals showed
less neurons per mm2 than older subjects did. We have to take
into account that during human life exists a critical period around
55–70 years old where there is an important incidence of stroke,
carcinogenic processes, and neurodegenerative diseases. In this
sense, individuals who reach 80 years old are the ones that were
able to throw this “bottleneck” and therefore could be the best
adapted, known as “SuperAgers” (Harrison et al., 2012; Gefen
et al., 2015). In this respect, some authors showed that these
nonagenarians have immunological and antioxidant defenses
and even episodic memory function equal or better than middle-
aged individuals (Moroni et al., 2005; Harrison et al., 2012; Gefen
et al., 2015).
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FIGURE 5 | Changes in neuronal density in hippocampus between men and women during AD progression (I-VI Braak’s stages). Representative
microphotographs of human brain sections of individuals with AD pathology, contrasted with a Nissl method modification. (A) Hippocampus (CA1) of a 70 years old
woman (Braak’s stage I). (B) Hippocampus (CA1) of a 75 years old woman (Braak’s stage V). (C) Hippocampus (CA3) of a 75 years old man (Braak’s stage I). (D)
Hippocampus (CA3) of an 80 years old man (Braak’s stage VI). Bar: 20µm.
TABLE 1 | Pearson coefficient of correlation between neuronal density
and Braak’s staging.
CA1 CA2 CA3 CA4 EC FC
WOMEN
Braak’s stage **r = −0.662 0 0 0 0 **r = −0.537
MEN
Braak’s stage 0 0 **r = −0.662 0 0 **r = −0.514
CA1–4, Hippocampal areas; EC, entorhinal cortex; FC, frontal cortex; **, correlation exists
with p < 0.001; 0, no correlation; r, correlation coefficient.
Unlike aging, the loss of neurons in AD pathology may
be due to a number of features that could facilitate or prone
neurodegeneration. In this sense, the presence of SP, resulted
from the abnormal extracellular accumulation and deposition of
the amyloid-β peptide (40 or 42 amino acids), seems to promote
neuronal death (Serrano-Pozo et al., 2011a). Several studies have
demonstrated that mature SP are associated with deleterious
effects on the surrounding neuropil i.e., increases of dystrophic
neurites, recruitment and activation of astrocytes and microglial
cells, synaptic loss, and neuronal death (Itagaki et al., 1989;
Masliah et al., 1990, 1994; Pike et al., 1995; Knowles et al., 1999;
Urbanc et al., 2002; Vehmas et al., 2003). Moreover, it is shown
that the number of neurons per area is lower near to the mature
SP than in distal areas in human and primate brains. The findings
described by Shah et al. (2010) unequivocally reflect that while
diffuse SP are commonly found in the brain of cognitive intact
elderly people, dense-core plaques are most often in patients with
AD dementia (Shah et al., 2010). In this work, we have observed
that SP content increases as the disease progresses, which would
explain the reduced neuronal density of these individuals.
Besides the SP, the presence of NFT, described as intraneural
filamentous inclusions whose major constituent is aberrantly
misfolded and abnormally hyperphosphorylated protein tau,
correlates with the severity of the pathology and consequently
with the neuronal loss in AD (Bierer et al., 1995; Gómez-Isla
et al., 1997; Giannakopoulos et al., 2003), as we described in the
Results section. However, whether NFT formation is a necessary
precursor of the neuronal death or represents a protective
response of damaged neurons in AD is still controversial.
Reactive astrocytes and activated microglial cells are
commonly associated to dense-core SP, indicating, according
with some authors, that amyloid-β peptide accumulation
is the major trigger of this glial response (Itagaki et al.,
1989; Pike et al., 1995; Vehmas et al., 2003). Our findings
demonstrated an increase in this reactive cells with aging
and with the Braak’s stages. However, it has been recently
described that the linear increase in reactive astrocytes and
activated microglial cells through the entire disease course
does not correlate with the amyloid deposition in the temporal
associative isocortex (Serrano-Pozo et al., 2011b). Indeed, it
has found a highly significant positive correlation between
astrocytosis or microgliosis and NFT burden but not with
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FIGURE 6 | Morphological brain changes in men and women during AD progression. Representative microphotographs of human brain sections of individuals
with AD pathology, contrasted with a silver technique of Reusche (A,B) and a modification of Congo Red method (C,D). (A) Diffuse and mature plaques in the
entorhinal cortex of an 80 years old man (Braak’s stage II). (B) Senile plaques and neurofibrillary tangles in the hippocampus (CA2) of an 85 years old woman (Braak’s
stage VI). (C) Diffuse and mature plaques (red fluorescence) in the entorhinal cortex of an 80 years old man (Braak’s stage II). (D) Senile plaques, in different maturation
stages, and neurofibrillary tangles (red fluorescence) in the entorhinal cortex of an 80 years old man (Braak’s stage VI). Bars: (A,C), 60µm; (B), 10µm; (D), 60µm.
amyloid concentration, suggesting that glial responses are related
to neurofibrillary degeneration (Serrano-Pozo et al., 2011b).
As we have shown, there are little differences in neuronal
density along aging in contrast to a clear loss of neurons in
the progression of AD. According to our data, these differences
not only depend on brain area but also on gender. In fact, in
the CA3 field we found a decrease in the number of neurons
per area in the non-pathological middle-aged men with respect
to women. One possible explanation for this difference is the
estrogen-mediated neuroprotection. Several authors pointed out
that the high plasma levels of estradiol that pre-menopausal
women show could exert a protective effect, preventing neuronal
degeneration (Ishunina et al., 2007; Henderson, 2014). In this
sense, in the first years after cessation of gonadal function women
may show less accumulated damage. After menopause, women
would become as vulnerable to neuronal degeneration as men,
coinciding with the reduction in the estrogen production. In
addition, sex differences were also found in the CA3 and CA4
hippocampal areas of the younger group. In these individuals,
the neuronal density was higher in men than in women. This is
in agreement with previous studies that show a higher neuronal
content but a lower synaptic density in men than women in some
brain areas (Allen and Gorski, 1991; Rabinowicz et al., 1999;
Zaidi, 2010). It seems that the greatest amount of estrogens in
brains of younger women could facilitate synaptic activity and
optimize neuronal function, thus less neurons would be necessary
to perform the same task (Aloisi et al., 1997; Brandt et al., 2013;
Fester and Rune, 2015).
In AD subjects, a decrease in the density of neurons in relation
to the stage of disease has been observed in the CA1 field in
women but not in men. On the contrary, in the CA3 field, are
men who lost more neurons. These observations are consistent
with a region-specific neuronal loss in AD, which depends on the
sex of the individuals and the stage of the pathology (Zaidi, 2010;
Padurariu et al., 2012). The decrease in the neuronal population
in AD may reflect the fact that the activation of antioxidant or
compensatory mechanisms in both, women and men, cannot
prevent neuronal loss in the brain. This phenomenon, together
with the proven existence of sexual dimorphism in certain brain
regions (Aloisi et al., 1997), could explain our results regarding
gender differences in the pattern of neuronal degeneration in AD
hippocampus; women seem to be more vulnerable in the CA1
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area, while men in the CA3. So far, it has been described that the
region-specific neuronal loss of this pathology occurs mainly in
the CA1 brain area in both sexes (Adachi et al., 2003; Kerchner
et al., 2010).
In summary, our findings clearly demonstrate that the
neuronal loss that takes place during aging and to a greater
degree in AD depends on the brain region and also varies
between women and men. Therefore, our study highlights the
need to consider the gender of the individuals in future studies
to discriminate sexual variations in the pathological progression.
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